Applications of second generation sequencing technologies in complex disorders
- PMID: 22331695
- DOI: 10.1007/7854_2011_196
Applications of second generation sequencing technologies in complex disorders
Abstract
Second generation sequencing (2ndGS) technologies generate unprecedented amounts of sequence data very rapidly and at relatively limited costs, allowing the sequence of a human genome to be completed in a few weeks. The principle is on the basis of generating millions of relatively short reads from amplified single DNA fragments using iterative cycles of nucleotide extensions. However, the data generated on this scale present new challenges in interpretation, data analysis and data management. 2ndGS technologies are becoming widespread and are profoundly impacting biomedical research. Common applications include whole-genome sequencing, target resequencing, characterization of structural and copy number variation, profiling epigenetic modifications, transcriptome sequencing and identification of infectious agents. New methodologies and instruments that will enable to sequence the complete human genome in less than a day at a cost of less than $1,000 are currently in development.
Similar articles
-
Current state-of-art of sequencing technologies for plant genomics research.Brief Funct Genomics. 2012 Jan;11(1):3-11. doi: 10.1093/bfgp/elr045. Brief Funct Genomics. 2012. PMID: 22345601 Review.
-
Applications of next-generation sequencing technologies in functional genomics.Genomics. 2008 Nov;92(5):255-64. doi: 10.1016/j.ygeno.2008.07.001. Epub 2008 Aug 24. Genomics. 2008. PMID: 18703132 Review.
-
Applications of ultra-high-throughput sequencing.Methods Mol Biol. 2009;553:79-108. doi: 10.1007/978-1-60327-563-7_5. Methods Mol Biol. 2009. PMID: 19588102 Review.
-
Characterizing and interpreting genetic variation from personal genome sequencing.Methods Mol Biol. 2012;838:343-67. doi: 10.1007/978-1-61779-507-7_17. Methods Mol Biol. 2012. PMID: 22228021
-
Next-generation sequencing: ready for the clinics?Clin Genet. 2012 Jun;81(6):503-10. doi: 10.1111/j.1399-0004.2012.01865.x. Epub 2012 Apr 9. Clin Genet. 2012. PMID: 22375550 Review.
Cited by
-
SP1 induced long non-coding RNA AGAP2-AS1 promotes cholangiocarcinoma proliferation via silencing of CDKN1A.Mol Med. 2021 Feb 1;27(1):10. doi: 10.1186/s10020-020-00222-x. Mol Med. 2021. PMID: 33522895 Free PMC article.
-
Long noncoding RNA MAPKAPK5-AS1 promotes colorectal cancer proliferation by partly silencing p21 expression.Cancer Sci. 2019 Jan;110(1):72-85. doi: 10.1111/cas.13838. Epub 2018 Dec 4. Cancer Sci. 2019. PMID: 30343528 Free PMC article.
-
Next-generation sequencing technologies accelerate advances in T-cell therapy for cancer.Brief Funct Genomics. 2019 Mar 22;18(2):119-128. doi: 10.1093/bfgp/ely018. Brief Funct Genomics. 2019. PMID: 29982317 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources